Netherlands Cancer Institute: NKI

Amsterdam 1066 CX

1 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumors, Metastatic Breast Cancer, Metastatic Castration-Resistant Prostate Cancer, Non Small Cell Lung Cancer, Non-small Cell Lung Cancer, ROS1-positive Non-Small Cell Lung Cancer (NSCLC)

Studies at this site

• Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC or Other ROS1+ Solid Tumors — Available (expanded access)
• Study to Evaluate CCS1477 in Advanced Tumours — Completed